Clinical Data Forgers Face Harsh Punishment In China
Executive Summary
China FDA now has more solid ground to enforce GCP norms. A legal explanation from the nation's highest People's Supreme Court clarifies responsibilities of study sponsors and CROs involving in data falsification.